retatrutide dosing clinical trials trial frequency Retatrutide Dosage Chart: Everything You Need to Know Reta clinical trial data &

However, for people with adequate biotin levels, additional supplementation has limited evidence for improving hair loss

Tirzepatide (Mounjaro, Zepbound) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for type 2 diabetes management and chronic weight management in adults with obesity or overweight with weight-related comorbidities

One study that is needed is a prospective randomized trial comparing the GLP-1/GIP agonists to placebo that has sound methodology and primary ocular outcomes

Unlike single-pathway medications, Tirzepatides dual mechanism helps improve blood sugar control while also contributing to significant weight loss a major advantage for patients who are overweight or obese